Skip to main content

Table 3 Procedural Results

From: Long-term clinical effectiveness of a drug-coated balloon for in-stent restenosis in Femoropopliteal lesions

Outcomes

Overall population

Matched population

PCB (n = 32)

Non-PCB (n = 74)

p

PCB (n = 25)

Non-PCB (n = 25)

p

Pre-dilatation

32 (100.0)

74 (100.0)

1.000

25 (100.0)

25 (100.0)

1.000

Balloon diameter of pre-dilatation, (mm)

5.27 ± 0.54

5.31 ± 0.64

0.729

5.22 ± 0.46

5.44 ± 0.56

0.137

Balloon/artery ratio of pre-dilatation

0.94 ± 0.11

0.96 ± 0.12

0.307

0.93 ± 0.10

0.99 ± 0.11

0.052

Balloon pressure of pre-dilatation, (atm)

11.5 ± 3.3

11.1 ± 3.0

0.526

11.5 ± 3.5

10.8 ± 2.7

0.441

The detail of PCB

 Diameter, (mm)

5.63 ± 0.79

5.60 ± 0.82

 Total length, (mm)

133.8 ± 52.7

137.6 ± 52.1

 Inflation time, (sec)

72.2 ± 32.2

74.4 ± 35.8

 Dilatation pressure, (atm)

9.1 ± 3.1

9.5 ± 3.4

Bail-out stenting

0 (0.0)

20 (27.0)

< 0.001

0 (0.0)

7 (28.0)

0.001

Complications

 Slow flow

3 (9.4)

5 (6.8)

0.695

2 (4.0)

1 (3.0)

1.000

 Distal embolization

2 (6.3)

3 (4.1)

0.637

2 (4.0)

0 (0.0)

0.490

 Vessel perforation

0 (0.0)

0 (0.0)

1.000

0 (0.0)

0 (0.0)

1.000

  1. Categorical variables are expressed as number and percentage. Continuous variables are indicated as mean ± SD
  2. PCB indicates paclitaxel-coated balloon